In a report released today, Peter Lawson from Barclays maintained a Buy rating on Kura Oncology (KURA – Research Report), with a price target of $32.00. The company’s shares closed yesterday ...

Kura Oncology (KURA) announced that on February 3, 2025, the Compensation Committee of the Company’s Board of Directors granted inducement awards consisting of nonstatutory stock options to ...

In an interview, Debra Patt, MD, PhD, MBA, FASCO, discusses the priorities of the Community Oncology Alliance as she starts ...

Two new measures tied to outcomes drawn from data in the CLEAR phase 3 trial will be presented during the ASCO Genitourinary ...

Operator Good afternoon, everyone, and welcome to Gilead's fourth quarter and full year 2024 earnings conference call. My ...

Oncology is the branch of medicine that deals with the diagnosis and treatment of cancer. It includes medical oncology (the use of chemotherapy, hormone therapy, and other drugs to treat cancer ...

Researchers observed improvements in rates of burnout and work-life integration challenges among a cohort of U.S. medical oncology fellows in 2023 vs. 2013, but challenges remain, according to ...

TheraBionic is the only FDA-approved therapy indicated in liver cancer patients that fail first-line and second-line therapy, so that's really the place it takes right now in 2025. Patients can ...

Operator Ladies and gentlemen, thank you for standing by and welcome to the Lilly Q4 2024 earnings call. [Operator instructions] I would now like to turn the conference over to your host, Mike Czapar, ...

After hours: February 7 at 7:26:59 PM EST ...

After hours: February 7 at 6:18:32 PM EST Loading Chart for CTOR ...

The shortage of generic chemotherapy drugs cisplatin and carboplatin that began in early 2023 did not increase short-term mortality rates among people with advanced cancer, according to results of ...